Summary
Definition
History and exam
Other diagnostic factors
- tachycardia
- tachypnea
- hypotension
- poor capillary refill
- acute mental confusion
- decreased urine output
- low oxygen saturation
- rash
- hepatosplenomegaly
- hypothermia
Risk factors
- use of central venous catheter
- exposure to broad-spectrum antibiotics
- colonization at multiple sites
- hemodialysis
- surgery
- parenteral nutrition
- immunosuppressants (e.g., chemotherapy, systemic corticosteroids)
- intravenous drug use
Diagnostic investigations
Treatment algorithm
Contributors
Authors
Dean and Professor of Medicine
Wayne State University School of Medicine
Detroit
MI
Disclosures
JDS declares that he has no competing interests.
Professor of Medicine
Division of Infectious Diseases
Wayne State University School of Medicine
Detroit
MI
Disclosures
SR has received grants for research from Astellas, Gilead, and Merck, and is involved in clinical trials for Cidara.
Peer reviewers
Professor of Medicine
Department of Medicine
Medical College of Georgia
Augusta
GA
Disclosures
JF is an author of a number of references cited in this monograph. JF is a member of the speaker's bureau for the following companies: Pfizer, Merck, and Astellas.
Praticien hospitalier
Service de medecine de la Transplantation et d'Immunologie clinique
Hopital Edouard Herriot
Lyon
France
Disclosures
JML has been invited by Astellas, the manufacturer of micafungin, to attend a symposium, and invited by Gilead Sciences, manufacturer of liposomal amphotericin B, to attend different HIV conferences, and has been paid by Gilead Sciences for running HIV educational programs.
Director
Alfa Institute of Biomedical Sciences
Marousi
Athens
Greece
Disclosures
MF declares that he has no competing interests.
Use of this content is subject to our disclaimer